86 related articles for article (PubMed ID: 27299796)
1. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
[TBL] [Abstract][Full Text] [Related]
2. Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients.
Tamaki K; Sasano H; Ishida T; Miyashita M; Takeda M; Amari M; Tamaki N; Ohuchi N
Cancer Sci; 2010 Sep; 101(9):2074-9. PubMed ID: 20557310
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors.
Selim AG; El-Ayat G; Wells CA
J Clin Pathol; 2002 Jan; 55(1):14-6. PubMed ID: 11825917
[TBL] [Abstract][Full Text] [Related]
4. Deep learning of mammogram images to reduce unnecessary breast biopsies: a preliminary study.
Liu C; Sun M; Arefan D; Zuley M; Sumkin J; Wu S
Breast Cancer Res; 2024 May; 26(1):82. PubMed ID: 38790005
[TBL] [Abstract][Full Text] [Related]
5. Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ.
Wu L; Zhao Y; Lin P; Qin H; Liu Y; Wan D; Li X; He Y; Yang H
BMC Med Imaging; 2021 May; 21(1):84. PubMed ID: 34001017
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma.
Pekmezci M; Szpaderska A; Osipo C; Erşahin C
Patholog Res Int; 2012; 2012():947041. PubMed ID: 22482085
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma
Zhu M; Kuang Y; Jiang Z; Liu J; Zhang H; Zhao H; Luo H; Chen Y; Peng Y
Gland Surg; 2024 Apr; 13(4):512-527. PubMed ID: 38720675
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
Milne RL; Goode EL; García-Closas M; Couch FJ; Severi G; Hein R; Fredericksen Z; Malats N; Zamora MP; Arias Pérez JI; Benítez J; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Cox A; Brock IW; Elliot G; Cross SS; Seal S; Turnbull C; Renwick A; Rahman N; Shen CY; Yu JC; Huang CS; Hou MF; Nordestgaard BG; Bojesen SE; Lanng C; Grenaker Alnæs G; Kristensen V; Børrensen-Dale AL; Hopper JL; Dite GS; Apicella C; Southey MC; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Chang-Claude J; Wang-Gohrke S; Radice P; Peterlongo P; Manoukian S; Barile M; Giles GG; Baglietto L; John EM; Miron A; Chanock SJ; Lissowska J; Sherman ME; Figueroa JD; Bogdanova NV; Antonenkova NN; Zalutsky IV; Rogov YI; Fasching PA; Bayer CM; Ekici AB; Beckmann MW; Brenner H; Müller H; Arndt V; Stegmaier C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Meindl A; Heil J; Bartram CR; Schmutzler RK; Thomas GD; Hoover RN; Fletcher O; Gibson LJ; dos Santos Silva I; Peto J; Nickels S; Flesch-Janys D; Anton-Culver H; Ziogas A; Sawyer E; Tomlinson I; Kerin M; Miller N; Schmidt MK; Broeks A; Van 't Veer LJ; Tollenaar RA; Pharoah PD; Dunning AM; Pooley KA; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Jakubowska A; Lubinski J; Jaworska K; Durda K; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Kraft P; Lindstrom S; Chen X; Beesley J; Hamann U; Harth V; Justenhoven C; ; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning M; Hollestelle A; Oldenburg RA; Tilanus-Linthorst M; Khusnutdinova E; Bermisheva M; Prokofieva D; Farahtdinova A; Olson JE; Wang X; Humphreys MK; Wang Q; Chenevix-Trench G; ; ; Easton DF
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2222-31. PubMed ID: 21795498
[TBL] [Abstract][Full Text] [Related]
9. Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients.
Kolacinska A; Morawiec J; Pawlowska Z; Szemraj J; Szymanska B; Malachowska B; Morawiec Z; Morawiec-Sztandera A; Pakula L; Kubiak R; Zawlik I
DNA Cell Biol; 2014 Sep; 33(9):624-9. PubMed ID: 24865188
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients.
Uy GB; Laudico AV; Carnate JM; Lim FG; Fernandez AM; Rivera RR; Mapua CA; Love RR
Clin Breast Cancer; 2010 Apr; 10(2):154-9. PubMed ID: 20299318
[TBL] [Abstract][Full Text] [Related]
11. Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer.
Dobrescu A; Chang M; Kirtani V; Turi GK; Hennawy R; Hindenburg AA
ISRN Oncol; 2011; 2011():673790. PubMed ID: 22091428
[TBL] [Abstract][Full Text] [Related]
12. Microinvasive Carcinoma versus Ductal Carcinoma
Kim M; Kim HJ; Chung YR; Kang E; Kim EK; Kim SH; Kim YJ; Kim JH; Kim IA; Park SY
J Breast Cancer; 2018 Jun; 21(2):197-205. PubMed ID: 29963116
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma.
Sasaki Y; Miki Y; Hirakawa H; Onodera Y; Takagi K; Akahira J; Honma S; Ishida T; Watanabe M; Sasano H; Suzuki T
Cancer Sci; 2010 Oct; 101(10):2286-92. PubMed ID: 20682005
[TBL] [Abstract][Full Text] [Related]
14. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.
Mattie MD; Benz CC; Bowers J; Sensinger K; Wong L; Scott GK; Fedele V; Ginzinger D; Getts R; Haqq C
Mol Cancer; 2006 Jun; 5():24. PubMed ID: 16784538
[TBL] [Abstract][Full Text] [Related]
15. The Incidence of Breast Cancer After Gender-Affirming Mastectomy in Transmen.
Parmeshwar N; Song S; Alcon A; Kim EA
Ann Plast Surg; 2022 May; 88(4 Suppl 4):S332-S336. PubMed ID: 35180758
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of hormone receptors with predictive value in mammary carcinomas.
Pleşan DM; Georgescu CV; Ciobotea S; Pătrană N; Mitroi L; Pleşan C
Curr Health Sci J; 2009 Jul; 35(3):184-9. PubMed ID: 24778819
[TBL] [Abstract][Full Text] [Related]
17. Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma.
Roca Navarro MJ; Oliver Goldaracena JM; Garrido Alonso D; Navarro Monforte Y; Díaz de Bustamante Durbán T; Córdoba Chicote MV; García Martínez F; Martí Álvarez C; Yébenes Gregorio L; Montes Botella JL; Martín Hervás C; Sánchez Méndez JI
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38814508
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of breast carcinoma as Paget disease of the skin at a prior core needle biopsy site: Case report and review of the literature.
Calvillo KZ; Guo L; Brostrom V; Schnitt SJ; Hong X; Raza S; Lester SC
Int J Surg Case Rep; 2015; 15():152-6. PubMed ID: 26395914
[TBL] [Abstract][Full Text] [Related]
19. Changes in breast cancer grade from biopsy to excision following surgery or primary chemotherapy.
Ferenczi Á; Cserni G
Pathologica; 2024 Feb; 116(1):22-31. PubMed ID: 38482672
[TBL] [Abstract][Full Text] [Related]
20. Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands.
Rajan KK; Nijveldt JJ; Verheijen S; Siesling S; Beek MA; Francken AB
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38874687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
